Skip to Main Content

WASHINGTON — Key Senate lawmakers have begun writing a bipartisan bill that would cap the prices patients pay for insulin — and target the strategies drugmakers use to set prices for the medicine, too.

The package, from Sens. Jeanne Shaheen (D-N.H.) and Sen. Susan Collins (R-Maine), would go beyond the $35-a-month cap lawmakers have been talking about for months, Shaheen suggested in a brief interview with STAT on Tuesday.


“We’re hopeful that we will have a bill that will address not just the cost cap… but the underlying cost,” she said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.